Antithrombin efficiency is maintained in vitro in human plasma following dilution with hydroxyethyl starches

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Hemodilution has been associated with changes in hemostasis secondary to modulation of procoagulant activity. However, direct effects of specific fluids on anticoagulants, such as antithrombin (AT), remained undefined. Thus, the purpose of this investigation was to determine whether hemodilution with hydroxyethyl starches (HES) directly diminishes plasma AT activity, which would be manifested by decreases in clot initiation time (reaction time, R) with thrombelastography greater than that seen with 0.9% NaCl (NS). Normal plasma and AT-deficient (< 1% activity) plasma were diluted 0 or 30% with NS, Hextend (6% HES; average molecular weight, 450 kDa), PentaLyte (6% HES; average molecular weight, 220 kDa), or Voluven (6% HES; average molecular weight, 130 kDa) (n = 6-7 experiments per condition). Undiluted, normal plasma had an R value of 796 ± 65 s, which was significantly (P < 0.05) greater than R values following NS (690 ± 50 s) or Voluven (675 ± 68 s) dilution. R values of normal plasma diluted with Hextend (831 ± 51 s) or PentaLyte (801 ± 72 s) were not different from undiluted plasma but were significantly (P < 0.05) greater than those observed following NS or Voluven dilution. There were no significant differences between the conditions when AT-deficient plasma was utilized (R range, 404-440 s). Rather than interfere with AT activity, HES with an average molecular weight of 220-450 kDa maintain AT efficiency.

Original languageEnglish (US)
Pages (from-to)319-322
Number of pages4
JournalBlood Coagulation and Fibrinolysis
Volume16
Issue number5
StatePublished - Jul 2005
Externally publishedYes

Fingerprint

Antithrombins
Starch
Molecular Weight
Hemodilution
Thrombelastography
In Vitro Techniques
Hemostasis
Anticoagulants
Reference Values
HES 130-0.4

Keywords

  • Antithrombin
  • Coagulation
  • Hemodilution
  • Monitoring
  • Thrombelastography

ASJC Scopus subject areas

  • Hematology

Cite this

@article{5184e4be763f491099e3388345228f0f,
title = "Antithrombin efficiency is maintained in vitro in human plasma following dilution with hydroxyethyl starches",
abstract = "Hemodilution has been associated with changes in hemostasis secondary to modulation of procoagulant activity. However, direct effects of specific fluids on anticoagulants, such as antithrombin (AT), remained undefined. Thus, the purpose of this investigation was to determine whether hemodilution with hydroxyethyl starches (HES) directly diminishes plasma AT activity, which would be manifested by decreases in clot initiation time (reaction time, R) with thrombelastography greater than that seen with 0.9{\%} NaCl (NS). Normal plasma and AT-deficient (< 1{\%} activity) plasma were diluted 0 or 30{\%} with NS, Hextend (6{\%} HES; average molecular weight, 450 kDa), PentaLyte (6{\%} HES; average molecular weight, 220 kDa), or Voluven (6{\%} HES; average molecular weight, 130 kDa) (n = 6-7 experiments per condition). Undiluted, normal plasma had an R value of 796 ± 65 s, which was significantly (P < 0.05) greater than R values following NS (690 ± 50 s) or Voluven (675 ± 68 s) dilution. R values of normal plasma diluted with Hextend (831 ± 51 s) or PentaLyte (801 ± 72 s) were not different from undiluted plasma but were significantly (P < 0.05) greater than those observed following NS or Voluven dilution. There were no significant differences between the conditions when AT-deficient plasma was utilized (R range, 404-440 s). Rather than interfere with AT activity, HES with an average molecular weight of 220-450 kDa maintain AT efficiency.",
keywords = "Antithrombin, Coagulation, Hemodilution, Monitoring, Thrombelastography",
author = "Nielsen, {Vance G}",
year = "2005",
month = "7",
language = "English (US)",
volume = "16",
pages = "319--322",
journal = "Blood Coagulation and Fibrinolysis",
issn = "0957-5235",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Antithrombin efficiency is maintained in vitro in human plasma following dilution with hydroxyethyl starches

AU - Nielsen, Vance G

PY - 2005/7

Y1 - 2005/7

N2 - Hemodilution has been associated with changes in hemostasis secondary to modulation of procoagulant activity. However, direct effects of specific fluids on anticoagulants, such as antithrombin (AT), remained undefined. Thus, the purpose of this investigation was to determine whether hemodilution with hydroxyethyl starches (HES) directly diminishes plasma AT activity, which would be manifested by decreases in clot initiation time (reaction time, R) with thrombelastography greater than that seen with 0.9% NaCl (NS). Normal plasma and AT-deficient (< 1% activity) plasma were diluted 0 or 30% with NS, Hextend (6% HES; average molecular weight, 450 kDa), PentaLyte (6% HES; average molecular weight, 220 kDa), or Voluven (6% HES; average molecular weight, 130 kDa) (n = 6-7 experiments per condition). Undiluted, normal plasma had an R value of 796 ± 65 s, which was significantly (P < 0.05) greater than R values following NS (690 ± 50 s) or Voluven (675 ± 68 s) dilution. R values of normal plasma diluted with Hextend (831 ± 51 s) or PentaLyte (801 ± 72 s) were not different from undiluted plasma but were significantly (P < 0.05) greater than those observed following NS or Voluven dilution. There were no significant differences between the conditions when AT-deficient plasma was utilized (R range, 404-440 s). Rather than interfere with AT activity, HES with an average molecular weight of 220-450 kDa maintain AT efficiency.

AB - Hemodilution has been associated with changes in hemostasis secondary to modulation of procoagulant activity. However, direct effects of specific fluids on anticoagulants, such as antithrombin (AT), remained undefined. Thus, the purpose of this investigation was to determine whether hemodilution with hydroxyethyl starches (HES) directly diminishes plasma AT activity, which would be manifested by decreases in clot initiation time (reaction time, R) with thrombelastography greater than that seen with 0.9% NaCl (NS). Normal plasma and AT-deficient (< 1% activity) plasma were diluted 0 or 30% with NS, Hextend (6% HES; average molecular weight, 450 kDa), PentaLyte (6% HES; average molecular weight, 220 kDa), or Voluven (6% HES; average molecular weight, 130 kDa) (n = 6-7 experiments per condition). Undiluted, normal plasma had an R value of 796 ± 65 s, which was significantly (P < 0.05) greater than R values following NS (690 ± 50 s) or Voluven (675 ± 68 s) dilution. R values of normal plasma diluted with Hextend (831 ± 51 s) or PentaLyte (801 ± 72 s) were not different from undiluted plasma but were significantly (P < 0.05) greater than those observed following NS or Voluven dilution. There were no significant differences between the conditions when AT-deficient plasma was utilized (R range, 404-440 s). Rather than interfere with AT activity, HES with an average molecular weight of 220-450 kDa maintain AT efficiency.

KW - Antithrombin

KW - Coagulation

KW - Hemodilution

KW - Monitoring

KW - Thrombelastography

UR - http://www.scopus.com/inward/record.url?scp=22444435270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22444435270&partnerID=8YFLogxK

M3 - Article

C2 - 15970714

AN - SCOPUS:22444435270

VL - 16

SP - 319

EP - 322

JO - Blood Coagulation and Fibrinolysis

JF - Blood Coagulation and Fibrinolysis

SN - 0957-5235

IS - 5

ER -